The development follows the completion of a Phase I study, which demonstrated an excellent safety profile for KINE-101.

I am examining the antigenicity of a protein in a novel drug delivery system. (Please see the accompanying research summary.) I am eager to bring the concepts I have learned in my project to the level ...

Innovative use of lipid nanoparticles to deliver immune agonists shows promise in activating anti-tumor immunity in ...

The recent development of dendrimeric peptides containing one copy of an FMDV T-cell epitope branching out into four copies of a B-cell epitope provides potential improvements over the ...

On the contrary, there is minimal expression of class I HLA antigens on hepatocytes, which favors decreased antigenicity. It is also thought that donor Kupffer cells may be replaced with host ...

As numerous HIV-infected chimpanzees are already available, no new infections should be initiated for this purpose. HIV strains differ widely in nucleic acid sequence, antigenicity, and pathogenicity.

SEOUL, South Korea I 13, 2024 I Kine Sciences, a clinical-stage, biopharmaceutical company developing small peptides for immune-mediated ...